Skip to main content

Veritas Capital Closes Vantage Fund

Fund to Leverage Veritas’ Integrated Platform and Intellectual Property to Continue to Invest and Create Value in Middle Market Technology Businesses

Oversubscribed Fund Hit Hard Cap in Two Months

Veritas Capital, a leading and longstanding investor in companies operating at the intersection of technology and government, today announced that it has completed fundraising for The Veritas Capital Vantage Fund (the “Vantage Fund”). The Fund closed at its hard cap with a total of $1.8 billion of committed capital.

The Vantage Fund was raised in two months following the Firm’s initial engagement with investors and was significantly oversubscribed. The closing of the Vantage Fund brings Veritas’ total assets under management to more than $28 billion.

The Vantage Fund will leverage the Firm’s extensive capabilities and intellectual property in technology investing to capitalize on compelling investment opportunities in the large, fragmented middle-market. The Vantage Fund provides an additional vehicle for investments that require less equity capital than the larger investments that are the focus of Veritas’ flagship funds. The closing of the Vantage Fund, together with Veritas Capital Fund VII and The Veritas Capital Credit Opportunities Fund, establishes the Firm as a differentiated partner with the ability to find highly-customized solutions for the companies in which it invests.

Since inception, Veritas has identified and driven the transformation of 100+ companies that provide critical products, services, and software to government-related and leading commercial customers worldwide. The Vantage Fund will continue the successful strategy of Veritas’ top performing flagship funds of investing exclusively at the intersection of technology and government, with a focus on investments in healthcare, education, and national security as well as software and communications.

“We are grateful for the tremendous confidence and support of both our existing limited partners and new investors, which enabled us to raise this fund so quickly,” said Ramzi Musallam, Chief Executive Officer and Managing Partner of Veritas Capital. “Veritas’ legacy is founded on investments in the middle-market, and this inaugural dedicated fund will harness our deep track record, highly synergistic, integrated investment platform and time-tested approach to value creation. The Vantage Fund is a natural expansion for us and will enable us to further leverage technology to make a positive impact and support the growth of more businesses across the vital areas of our target industries.”

The closing of the Vantage Fund follows an active year for Veritas. Since March 2020, Veritas has executed acquisitions with over $23 billion in total enterprise value, including $2.6 billion of co-investment commitments in support of those investments.

About Veritas Capital

Veritas is a longstanding investor in companies operating at the intersection of technology and government. The firm invests in companies that provide critical products, services, and software, primarily technology and technology-enabled solutions, to government and commercial customers worldwide, including those operating in the healthcare, national security, software, education, aerospace & defense, government services, communications, and energy industries. Veritas seeks to create value by strategically transforming the companies in which it invests through organic and inorganic means.

Leveraging technology to make a positive impact across vitally important areas, such as healthcare, education, and national security, is core to Veritas. We are proud stewards of national assets, helping to improve the quality of healthcare while reducing cost, advance our educational system, and protect our nation and allies. For more information, visit www.veritascapital.com.

Contacts

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.